Skip to main content
Premium Trial:

Request an Annual Quote

Incogen Receives Remaining $1.2M NIH Funding for Cancer Dx Software Project

NEW YORK, April 4 (GenomeWeb News) - Incogen said last week that after meeting first-year milestones, it has received the $1.2 million remaining on a $2-million National Institutes of Health grant.

 

According to Incogen, the grant will help support its research into cancer diagnostics, and involves a collaboration with researchers from the College of William and from the EasternVirginiaMedicalSchool.

 

The NIH award is a Phase II follow-on to a previous grant received in 2003, Incogen said. That first grant provided funding for the development of a pilot project in the analysis of data obtained from surface-enhanced laser desorption ionization mass spectrometry.

 

The Phase II work is focused on developing a clinical diagnostic software package based on Incogen's Visual Integrated Bioinformatics Environment software.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.